Company Cempra Inc Nasdaq
Equities
US15130J1097
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 20-08-02 | |
Susan Blum
DFI | Director of Finance/CFO | 52 | 21-06-30 |
Compliance Officer | 45 | - | |
Jisoo Park
PRN | Corporate Officer/Principal | - | 21-07-05 |
Kristen Allgor
HRO | Human Resources Officer | - | 20-11-15 |
John Harlow
PRN | Corporate Officer/Principal | - | 21-03-29 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Leff
BRD | Director/Board Member | 55 | 20-04-19 |
Director/Board Member | - | 20-04-19 | |
Director/Board Member | - | 20-04-19 | |
Compliance Officer | 45 | - | |
Chief Executive Officer | 48 | 20-08-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,750,691 | 13,578,334 ( 98.75 %) | 0 | 98.75 % |
Company contact information
Melinta Therapeutics, Inc.
389 Interpace Parkway Suite 450
07054, Parsippany
+908-617-1300
http://melinta.comSector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |